NASDAQ:BNGO
Bionano Genomics, Inc.
- Stock
Last Close
1.11
17/05 20:00
Market Cap
47.39M
Beta: 2.26
Volume Today
865.05K
Avg: 7.20M
PE Ratio
−0.17
PFCF: −0.32
Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|
net income | -18.85M - | -23.37M 23.96% | -18.50M 20.84% | -29.82M 61.19% | -41.11M 37.87% | -72.44M 76.21% | -132.60M 83.06% | -232.49M 75.34% | |
depreciation and amortization | 1.12M - | 1.50M 34.89% | 1.32M 12.20% | 1.13M 14.59% | 1.48M 31.18% | 3.37M 127.77% | 9.84M 191.99% | 13.71M 39.31% | |
deferred income tax | -3.01M - | 479.01K 115.93% | -2.46M 613.33% | 1.90M 177.28% | 1.93M 1.81% | -5.78M 398.61% | 1.76M 130.47% | 8.44M 379.60% | |
stock based compensation | 130.64K - | 382.83K 193.04% | 1.31M 242.02% | 1.35M 2.80% | 1.55M 15.46% | 9.72M 525.39% | 22.42M 130.65% | 15.18M 32.29% | |
change in working capital | -2.96M - | 85.10K 102.87% | -2.37M 2,883.53% | -4.97M 109.89% | -3.44M 30.81% | -7.65M 122.43% | -28.59M 273.60% | -14.77M 48.34% | |
accounts receivables | -856.10K - | -1.77M 106.48% | -900.12K 49.08% | -2.37M 163.80% | 2.09M 187.89% | -493K 123.62% | -2.90M 488.24% | -2.30M 20.83% | |
inventory | -726.14K - | -336.05K 53.72% | -418.98K 24.68% | -3.64M 769.01% | -4.20M 15.39% | -15.93M 279.12% | -23.68M 48.64% | -4.15M 82.47% | |
accounts payables | -608.65K - | 1.54M 353.26% | -954.38K 161.91% | 1.36M 242.75% | -1.81M 232.80% | 6.78M 474.78% | 1.95M 71.26% | -2.00M 202.36% | |
other working capital | -770.34K - | 647.32K 184.03% | -95.39K 114.74% | -318.96K 234.37% | 483.49K 251.58% | 1.99M 311.18% | -3.96M 299.25% | -6.33M 59.76% | |
other non cash items | 73.90K - | 96.58K 30.68% | 750.47K 677.08% | 883.27K 17.69% | 1.26M 43.09% | 848K 32.91% | 2.35M 177.24% | 80.23M 3,312.72% | |
net cash provided by operating activities | -23.50M - | -20.82M 11.40% | -19.94M 4.20% | -29.53M 48.06% | -38.31M 29.75% | -71.93M 87.73% | -124.82M 73.53% | -129.70M 3.91% | |
investments in property plant and equipment | -1.35M - | -1.02M 24.60% | -331.72K 67.41% | -61.06K 81.59% | -1.46M - | -3.30M 126.16% | -1.69M 48.79% | ||
acquisitions net | -2.45M - | -49.09M 1,903.55% | -31.34M 36.14% | 96K 100.31% | |||||
purchases of investments | -313.39M - | -84.19M 73.13% | -111.26M 32.15% | ||||||
sales maturities of investments | 86.48M - | 200.89M 132.29% | 137.02M 31.79% | ||||||
other investing activites | -607K - | 720K 218.62% | |||||||
net cash used for investing activites | -1.35M - | -1.02M 24.60% | -331.72K 67.41% | -61.06K 81.59% | -2.45M 3,912.63% | -278.06M 11,249.69% | 82.77M 129.77% | 24.16M 70.81% | |
debt repayment | -5M - | -7.45M - | -14.43M 93.72% | -7.26M 49.69% | -15.01M 106.72% | -36K 99.76% | -9.05M 25,030.56% | ||
common stock issued | 19.39M - | 19.56M 0.86% | 39.93M 104.20% | 342.71M 758.19% | 23.13M 93.25% | 56.38M 143.79% | |||
common stock repurchased | -2M - | ||||||||
dividends paid | -2M - | ||||||||
other financing activites | 30.43M - | 17.61M 42.14% | 23.83M 35.36% | 25.25M 5.94% | 33.23M 31.59% | 8.40M 74.70% | -85K 101.01% | 71M 83,629.41% | |
net cash used provided by financing activities | 25.43M - | 17.61M 30.76% | 35.78M 103.18% | 30.38M 15.09% | 61.90M 103.76% | 336.11M 442.98% | 23.01M 93.15% | 118.34M 414.35% | |
effect of forex changes on cash | -38K - | 65K 271.05% | |||||||
net change in cash | 584.85K - | -4.23M 822.87% | 15.50M 466.65% | 788.64K 94.91% | 21.14M 2,580.21% | -13.88M 165.66% | -19.08M 37.48% | 47.97M 351.44% | |
cash at beginning of period | 4.66M - | 5.25M 12.54% | 1.02M 80.53% | 16.52M 1,516.87% | 17.31M 4.77% | 38.45M 122.10% | 24.57M 36.09% | 5.09M 79.28% | |
cash at end of period | 5.25M - | 1.02M 80.53% | 16.52M 1,516.87% | 17.31M 4.77% | 38.45M 122.10% | 24.57M 36.09% | 5.49M 77.65% | 53.06M 866.40% | |
operating cash flow | -23.50M - | -20.82M 11.40% | -19.94M 4.20% | -29.53M 48.06% | -38.31M 29.75% | -71.93M 87.73% | -124.82M 73.53% | -129.70M 3.91% | |
capital expenditure | -1.35M - | -1.02M 24.60% | -331.72K 67.41% | -61.06K 81.59% | -1.46M - | -3.30M 126.16% | -1.69M 48.79% | ||
free cash flow | -24.85M - | -21.84M 12.12% | -20.28M 7.14% | -29.59M 45.94% | -38.31M 29.48% | -73.39M 91.54% | -128.12M 74.58% | -131.39M 2.56% |
All numbers in USD (except ratios and percentages)